Gene Silencing in the Development of Personalized Cancer Treatment: The Targets, the Agents and the Delivery Systems

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|6|4|505-533

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.6, Iss.4, 2006-08, pp. : 505-533

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Prominent Role of Protein-Based Delivery Systems on the Development of Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 22, Iss. 22, 2016-06 ,pp. : 3455-3465

Bentham Science Publishers

Access to resources Recommend Favorite

An overview of current delivery systems in cancer gene therapy

By El-Aneed A.  

Journal of Controlled Release, Vol. 94, Iss. 1, 2004-01 ,pp. : 1-14

Elsevier

Access to resources Recommend Favorite

Lipid-Based Drug Delivery Systems for Cancer Treatment

By  

Current Drug Targets, Vol. 12, Iss. 8, 2011-07 ,pp. : 1151-1165

Bentham Science Publishers

Access to resources Recommend Favorite

Delivery Strategies for siRNA-mediated Gene Silencing

By  

Current Drug Delivery, Vol. 3, Iss. 2, 2006-04 ,pp. : 147-155

Bentham Science Publishers

Access to resources Recommend Favorite

Systems Biology and Personalized Medicine in Cancer

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 1, 2010-03 ,pp. : 64-72

Bentham Science Publishers

Access to resources Recommend Favorite